中东和非洲药物-设备组合市场，按产品（自动注射器、微针贴片、数字药丸、智能吸入器、药物输送水凝胶、药物洗脱镜片等）、应用类型（骨科疾病、呼吸系统疾病、糖尿病、肿瘤学、心血管疾病等）、最终用户（诊所、医院、家庭护理机构、门诊护理中心等）、分销渠道（直接招标、零售销售等）、国家（南非和中东及非洲其他地区）行业趋势和预测到 2028 年。
市场分析与洞察：中东和非洲药械组合市场
预计药械组合市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，市场将以 8.7% 的复合年增长率增长，预计到 2028 年将从 2020 年的 6.789 亿美元达到 12.744 亿美元。医疗器械需求的增加和政府举措的增多是预测期内推动市场需求的主要驱动力。
慢性病患病率的上升和科技进步有效促进了药物-器械组合市场的增长。然而，药物-器械组合产品的局限性和复杂性可能会阻碍药物-器械组合市场未来的增长。主要市场参与者的伙伴关系和合作是一个机遇。然而，严格的监管框架对药物-器械组合市场的增长是一个挑战。
药物-器械组合市场报告提供了市场份额、新发展和产品线分析的详细信息，国内和本地市场参与者的影响，分析了新兴收入领域、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
中东和非洲药物-设备组合 - 市场范围和市场规模
中东和非洲药物-设备组合市场根据产品、应用、最终用户和分销渠道分为四个显著的部分。
- 根据产品，药物-设备组合市场细分为自动注射器、微针贴片、数字药丸、智能吸入器、药物输送水凝胶、药物洗脱镜片等。2021 年，随着对高度先进和高效的药物-设备组合治疗技术的需求不断增长，自动注射器在医疗器械市场中占有最高份额。
- 根据应用，药械组合市场细分为骨科疾病、呼吸系统疾病、糖尿病、肿瘤、心血管疾病等。2021 年，预计骨科将主导药械组合市场，因为技术增长潜力增加，尤其是在医疗器械和医疗保健领域，再加上针对普遍健康状况的先进医疗辅助设备的日益普及，预计将推动市场进一步增长。
- 根据最终用户，药械组合市场细分为诊所、医院、家庭护理机构、门诊护理中心等。预计 2021 年诊所将主导药械组合市场，因为大多数患者更愿意接受专家的监测和治疗，以避免进一步的并发症。
- 根据分销渠道，药械组合市场分为直接招标、零售和其他。到 2021 年，由于医院和诊所的可用性增加以及国际贸易体系的不断发展，预计直接招标将主导药械组合市场。
药械组合市场国家层面分析
对药物-设备组合市场进行分析，并按产品、应用、最终用户和分销渠道提供市场规模信息。
药品-设备组合市场报告涵盖的国家包括南非和中东及非洲其他地区。
在中东和非洲国家中，预计南非将在 2021 年至 2028 年的预测期内以可观的增长率增长。政府机构和医疗保健组织正在该地区开展各种计划；因此，预计这将推动市场增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，销售渠道的影响。
与当地企业不断增长的合作伙伴关系和分销协议为药械组合市场参与者创造了新的机会
药械组合市场还为您提供了每个国家药械组合产品行业增长的详细市场分析。此外，它还提供有关与当地参与者建立合作伙伴关系和分销协议的详细信息。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和市场份额分析
药物-器械组合市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对药物-器械组合市场的关注有关。
报告中涉及的主要参与者包括美敦力、安进公司、BD、Eitan Medical、E3D Elcam 药物输送设备、葛兰素史克公司、拜耳公司、NanoPass、杨森制药公司（强生服务公司的子公司）、大冢美国制药公司，以及其他国内和中东及非洲参与者。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
许多产品的审批也由世界各地的公司发起，这也加速了药械组合市场的发展。
例如，
- 2021 年 7 月，Eitan Medical 宣布通过开设德国总部来扩大业务。此次向欧洲的扩张增加了对不断增长的客户群的支持
- 2020 年 10 月，葛兰素史克公司宣布，欧洲药品管理局 (EMA) 已接受监管申请，寻求批准抗 IL5 生物制剂 Nucala (mepolizumab) 用于治疗另外三种疾病：嗜酸性粒细胞增多症 (HES)、伴有鼻息肉的慢性鼻窦炎 (CRSwNP) 和伴有多血管炎的嗜酸性肉芽肿 (EGPA)。这增加了公司的收入，从而吸引了更多客户
- 2018 年 9 月，安进公司获得日本厚生劳动省对 Blincyto（blinatumomab）的上市许可。Blincyto（blinatumomab）的一线用途是治疗复发或难治性 B 细胞急性淋巴细胞白血病。此项批准加速了该公司在日本市场的地位
市场参与者的合作、合资和其他策略正在增强公司在药品-设备组合市场的地位，这也为组织带来了利益。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PATENT ANALYSIS
4.1.1 MANUFACTURING PROCESS OF COMBINATION PRODUCTS
4.1.2 APPROVAL BY AGENCY
4.1.3 PATENT GRANT
4.1.4 PATENT CERTIFICATIONS:
5 PIPELINE ANALYSIS
6 REGULATORY FRAMEWORKS:
6.1 U.S.
6.2 EUROPE
6.3 CANADA
6.4 AUSTRALIA
6.5 JAPAN
6.6 CHINA
6.7 SOUTH KOREA
7 REGIONAL SUMMARY
7.1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.1.1 OVERVIEW
7.2 EUROPE DRUG-DEVICE COMBINATION MARKET
7.2.1 OVERVIEW
7.3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
7.3.1 OVERVIEW
7.4 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET
7.4.1 OVERVIEW
7.5 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.5.1 OVERVIEW
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
8.1.2 GROWING GERIATRIC POPULATION
8.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES
8.1.4 RISING RATES OF OBESITY
8.2 RESTRAINTS
8.2.1 PRODUCT RECALLS
8.2.2 RISK ASSOCIATED WITH THE COMBINATION PRODUCTS
8.3 OPPORTUNITIES
8.3.1 RISING EXPENDITURE ON HEALTHCARE
8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
8.3.3 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES
8.3.4 INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
8.4 CHALLENGE
8.4.1 STRICT REGULATORY FRAMEWORK
9 IMPACT OF COVID-19 PANDEMIC ON THE MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON SUPPLY CHAIN
9.3 IMPACT ON DEMAND
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT
10.1 OVERVIEW
10.2 AUTO-INJECTOR
10.2.1 WEARABLE AUTO-INJECTOR
10.2.2 HAND HELD AUTO-INJECTOR
10.3 MICRONEEDLE PATCH
10.4 DIGITAL PILL
10.5 SMART INHALER
10.6 DRUG DELIVERY HYDROGELS
10.7 DRUG-ELUTING LENS
10.8 OTHERS
11 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ORTHOPEDIC DISEASES
11.3 RESPIRATORY DISEASES
11.4 DIABETES
11.5 ONCOLOGY
11.6 CARDIOVASCULAR DISEASES
11.7 OTHERS
12 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER
12.1 OVERVIEW
12.2 CLINICS
12.3 HOSPITALS
12.4 HOME CARE SETTINGS
12.5 AMBULATORY CARE CENTERS
12.6 OTHERS
13 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAILS SALES
13.4 OTHERS
14 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY REGION
14.1 MIDDLE EAST AND AFRICA
14.1.1 SOUTH AFRICA
14.1.2 REST OF MIDDLE EAST AND AFRICA
15 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 AMGEN INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 GLAXOSMITHKLINE PLC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 BD
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 MEDTRONIC
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 BAYER AG
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 CGBIO
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 COSMED PHARMACEUTICAL CO.LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 E3D ELCAM DRUG DELIVERY DEVICES
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 EITAN MEDICAL
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 EOFLOW CO., LTD.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 FINDAIR SP. Z O. O.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 INSULET CORPORATION
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 MEDIPRINT
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 METP PHARMA AG
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 MICRON BIOMEDICAL, INC.
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 NANOPASS
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 OCUMEDIC
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 OTSUKA AMERICA PHARMACEUTICAL, INC.
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 PROPELLER HEALTH
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 RAPHAS CO., LTD.
17.21.1 COMPANY SNAPSHOT
17.21.2 REVENUE ANALYSIS
17.21.3 PRODUCT PORTFOLIO
17.21.4 RECENT DEVELOPMENT
17.22 SENSIRION AG SWITZERLAND
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 . SONCEBOZ
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENT
17.24 SUBCUJECT APS
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 THERAJECT
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
17.26 VAXESS TECHNOLOGIES INC.
17.26.1 COMPANY SNAPSHOT
17.26.2 PRODUCT PORTFOLIO
17.26.3 RECENT DEVELOPMENTS
17.27 VAXXAS
17.27.1 COMPANY SNAPSHOT
17.27.2 PRODUCT PORTFOLIO
17.27.3 RECENT DEVELOPMENTS
17.28 YPSOMED
17.28.1 COMPANY SNAPSHOT
17.28.2 REVENUE ANALYSIS
17.28.3 PRODUCT PORTFOLIO
17.28.4 RECENT DEVELOPMENTS
17.29 ZIMMER BIOMET
17.29.1 COMPANY SNAPSHOT
17.29.2 REVENUE ANALYSIS
17.29.3 PRODUCT PORTFOLIO
17.29.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST AND AFRICA DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS
TABLE 2 MOST OBESE COUNTRIES OF ASIA-PACIFIC 2020
TABLE 3 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA MICRONEEDLE PATCH IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA DIGITAL PILL IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA SMART INHALER IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DRUG DELIVERY HYDROGELS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA DRUG-ELUTING LENS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA ORTHOPEDIC DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA RESPIRATORY DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA DIABETES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA ONCOLOGY IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA CLINICS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA HOSPITALS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA HOME CARE SETTINGS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA DIRECT TENDER IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA RETAIL SALES IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 35 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 SOUTH AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 37 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 38 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 REST OF MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: PRODUCT TYPE LIFELINE CURVE
FIGURE 8 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 13 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 THE AUTO-INJECTOR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET IN THE YEAR 2021 & 2028
FIGURE 15 PORTER'S 5 FORCES
FIGURE 16 PESTEL'S MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET
FIGURE 18 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.
FIGURE 19 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 20 AGEING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 21 NORTH AMERICA AGEING POPULATION (IN MILLION)
FIGURE 22 EUROPE AGEING POPULATION (IN MILLION)
FIGURE 23 ASIA-PACIFIC AGEING POPULATION (IN MILLION)
FIGURE 24 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES, 2016
FIGURE 25 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2020
FIGURE 26 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 28 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 29 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2020
FIGURE 30 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY END USER, 2020
FIGURE 34 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2021-2028 (USD MILLION)
FIGURE 35 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 36 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 37 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 38 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 39 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 40 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 42 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 43 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 44 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 45 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT (2021-2028)
FIGURE 46 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
